Pages that link to "Item:Q4796210"
From MaRDI portal
The following pages link to Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design (Q4796210):
Displaying 9 items.
- Operating characteristics of the standard phase I clinical trial design. (Q1285808) (← links)
- Bayesian two-stage design for phase II clinical trials with switching hypothesis tests (Q1699638) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Two-stage phase II trials with early stopping for effectiveness and safety as well as ineffectiveness or harm (Q5076974) (← links)
- A Bayesian seamless phase I–II trial design with two stages for cancer clinical trials with drug combinations (Q5135528) (← links)
- A Three-Stage Bayesian Adaptive Phase I/II Design and Simulation Studies (Q5417921) (← links)
- (Q5434036) (← links)
- Two‐Stage Designs for Dose‐Finding Trials with a Biologic Endpoint Using Stepwise Tests (Q5450485) (← links)
- A system for determining maximum tolerated dose in clinical trial (Q5880093) (← links)
